Home | Welcome to Contract Pharma   
Last Updated Thursday, November 27 2014


The engineering of an antibody protein sequence to make it more human like and less antigenic during therapeutic use.

blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On